MedPath

VR for Pain Management During Adult Burn Dressing Change

Not Applicable
Completed
Conditions
Pain
Burns
Interventions
Other: VR-based Pain Alleviation Tool (VR-PAT)
Registration Number
NCT04545229
Lead Sponsor
Nationwide Children's Hospital
Brief Summary

A randomized controlled trial to evaluate the efficacy of the VR-based Pain Alleviation Tool (VR-PAT) in reducing opioid pain medication use during adult burn dressing changes.

Detailed Description

A pilot three group gender-balanced randomized clinical trial (RCT) among adult burn patients (18 years old or above) at OSU Medical Center Inpatient Burn Program. The intervention group will receive VR-PAT as a distraction tool during the dressing change procedure (active VR group) while the comparison groups will receive either a comparable passive VR distraction tool that uses the same hardware and visual/audio features, but requires no active interaction (Control Group 1), or no distraction at all (Control Group 2).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  1. Adult burn patient age 18-70
  2. First admission for acute burn requiring dressing change
  3. First admission for burn injury
  4. Using Opioids for dressing changes
  5. Burn is ≤ 4 days post burn
Exclusion Criteria
  1. Severe burn(s) on the face/head preventing utilization of VR
  2. Cognitive/motor impairment preventing valid administration of study measures
  3. Unable to communicate in English
  4. Prisoners and patients who were pregnant
  5. Patients admitted to the ICU

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active VR-PATVR-based Pain Alleviation Tool (VR-PAT)Active VR-based Pain Alleviation Tool (VR-PAT) group played smart phone VR-PAT during the burn dressing changes.
Passive VR-PATVR-based Pain Alleviation Tool (VR-PAT)Passive VR-based Pain Alleviation Tool (VR-PAT) group watched smart phone VR-PAT games without interaction during the burn dressing changes.
Primary Outcome Measures
NameTimeMethod
Patient self-reported painDuring burn dressing changes

Patient self-reported pain using the 100mm Visual Analog Scale (VAS), 0 (min)-100(max), higher score for worse outcome.

Secondary Outcome Measures
NameTimeMethod
Opioid medication utilization, morphine equivalent dose per day during inpatient hospital stay.Each day during inpatient hospital stays up to 7 days.

Opioid pain medication use (converted to morphine equivalent dose), obtained through patient medical administration records. This data will be used as morphine equivalent dose per day, total morphine-equivalent dose during hospital stay, and average morphine-equivalent dose among active VR group, passive VR group, and standard care group in comparison.

Trial Locations

Locations (1)

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath